▪️ Serves as a technical lead and principal investigator for pharmacokinetic and immunogenicity assay development and validation of drugs on ELISA and MSD platforms. ▪️ Calculates, interprets, and records data in adherence with standards of procedure and any additional requirements specific to industry standards, lab, and / or clients.▪️ Builds and maintains relationships with outside stakeholders to present updates, reviews and evaluations of data.▪️ Provides troubleshooting and support on multiple analytical platforms.▪️ Responsible for the regulatory and scientific conduct that adhere to the principles of GLP.

▪️Original Covid-19 team member; rapidly onboarded new software and databases that enabled high throughput patient testing needed during the global pandemic ▪️Performed trend analysis on a wide variety of molecular biology methodologies, including characterization/interpretation of results, and user assigned testing of new laboratory software

▪️ Conducted a variety of routine to complex sample preparation and analysis procedures to quantitatively measure pharmaceutical and bio-pharmaceutical compounds in a variety of formulations and/or biological matrices▪️ Reviewed and compiled results and data in comparison to Standard Laboratory Procedure acceptance criteria, methodology, protocol and product specifications

▪️Worked across multiple departments to prepare and test samples in a timely manner, conducted ELISA and immunoassay to analyze individual saliva and urine samples for substance abuse